Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by Law.com, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!

X

More On

AstraZeneca Raided By European Antitrust Officials

AstraZeneca Plc, the U.K.'s second- biggest drugmaker, was raided by European Union antitrust officials as part of a probe into whether companies colluded to keep cheaper copies of medicines off the market.

The European Commission said it raided the premises of "a limited number of" pharmaceutical companies that may have slowed the sale of generic medicines. AstraZeneca said inspections at its premises concerned the ulcer drug Nexium.

For the complete Bloomberg story, click here.

Join the Conversation

Advertisement. Closing in 15 seconds.